Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Zipprich

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|September 5, 2019
Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular CarcinomaMaurice Michel, Marcus Hollenbach, Sabine Pohl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 4, 2025
Liver sinusoidal endothelial cells: Friend or foe in metabolic dysfunction- associated steatotic liver disease/metabolic dysfunction-associated steatohepatitisQingqing Dai, Quratul Ain, Navodita Seth, et al.
Plos One|March 21, 2015
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosisMiriam Moeller, Antje Thonig, Sabine Pohl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2025
Influence of Low-dose Acetylsalicylic Acid on Renal Function in Patients With Liver Cirrhosis and AscitesHenrik Karbannek, Marina Reljic, Andreas Stallmach, et al.
Journal of Clinical Gastroenterology|January 20, 2015
Serum Ferritin in Patients With Cirrhosis is Associated With Markers of Liver Insufficiency and Circulatory Dysfunction, but Not of Portal HypertensionCristina Ripoll, Felix Keitel, Marcus Hollenbach, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 9, 2020
Effect of ET-A blockade on portal pressure and hepatic arterial perfusion in patients with cirrhosis: A proof of concept studyAlexander Zipprich, Fleur Gittinger, Matthias Winkler, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 24, 2008
The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liverAlexander Zipprich, Mauricio R Loureiro-Silva, Irita D'Silva, et al.
Aging Cell|February 6, 2025
Aging-Associated Liver Sinusoidal Endothelial Cells Dysfunction Aggravates the Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseQingqing Dai, Quratul Ain, Navodita Seth, et al.
Zeitschrift Fur Gastroenterologie|July 11, 2022
Martin Götz, Erwin Biecker, Alexander Dechêne, et al.
Plos One|February 24, 2017
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosisMarcus Hollenbach, Antje Thonig, Sabine Pohl, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|September 5, 2019
Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular CarcinomaMaurice Michel, Marcus Hollenbach, Sabine Pohl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 4, 2025
Liver sinusoidal endothelial cells: Friend or foe in metabolic dysfunction- associated steatotic liver disease/metabolic dysfunction-associated steatohepatitisQingqing Dai, Quratul Ain, Navodita Seth, et al.
Plos One|March 21, 2015
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosisMiriam Moeller, Antje Thonig, Sabine Pohl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2025
Influence of Low-dose Acetylsalicylic Acid on Renal Function in Patients With Liver Cirrhosis and AscitesHenrik Karbannek, Marina Reljic, Andreas Stallmach, et al.
Journal of Clinical Gastroenterology|January 20, 2015
Serum Ferritin in Patients With Cirrhosis is Associated With Markers of Liver Insufficiency and Circulatory Dysfunction, but Not of Portal HypertensionCristina Ripoll, Felix Keitel, Marcus Hollenbach, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 9, 2020
Effect of ET-A blockade on portal pressure and hepatic arterial perfusion in patients with cirrhosis: A proof of concept studyAlexander Zipprich, Fleur Gittinger, Matthias Winkler, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 24, 2008
The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liverAlexander Zipprich, Mauricio R Loureiro-Silva, Irita D'Silva, et al.
Aging Cell|February 6, 2025
Aging-Associated Liver Sinusoidal Endothelial Cells Dysfunction Aggravates the Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseQingqing Dai, Quratul Ain, Navodita Seth, et al.
Zeitschrift Fur Gastroenterologie|July 11, 2022
Martin Götz, Erwin Biecker, Alexander Dechêne, et al.
Plos One|February 24, 2017
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosisMarcus Hollenbach, Antje Thonig, Sabine Pohl, et al.
Pageof 12